Thomas Clozel, Owkin | What does AI Biotech really mean | E10
In an online special, we’re interviewing Thomas Clozal, the co-founder and CEO of Owkin. We...
Marc de Garidel, Abivax | How to make two Billion-dollar exits (“smoothly”) | E09
Today, I’m in Paris to chat with Marc de Garidel, the new CEO of Abivax....
Mike Ward | The Best and the Worst since the 80s in EU Biotech | E08
Today we’re in Munich at BIO-Europe to chat with one of the best commentators in...
Agnete Fredriksen, Nykode | Being one of the top 50 women in 🇪🇺 bio | E07
We’re live from Oslo 🇳🇴 to catch up with Agnete Fredriksen, co-founder and CBO of Nykode...
Rodger Novak, CRISPR Tx | #1 CRISPR Drug | E06
Biotech great Rodger Novak, Co-Founder and Chairman of CRISPR Tx joins us on the show....
Johannes Fruehauf, BioLabs | Reinventing Biotech Incubators | E05
We’re back live and in Paris with our next guest, Johannes Fruehauf. We talk about...
Bernat Olle, Vedanta | Best Microbiome Therapeutics | E04
In a virtual special, we welcome Bernat Olle to the show. We discuss the microbiome...
Ingmar Hoerr, CureVac | Founding a €20B Biotech | E03
It’s a treat to welcome Ingmar Hoerr on the show. We chat about building a...
Werner Lanthaler, Evotec | Leading AI in Biotech | E02
It’s great to have Werner Lanthaler, the CEO of Evotec, one of the largest biotech...
Antoine Papiernik, Sofinnova | Billion Investing with Balance | E01
For our first episode, we catch up with Antoine Papiernik, the chairman of Sofinnova Partners,...
Never Miss a New Episode 💌
Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.
Watch & Subscribe
